Coupling an artificial receptor with macrophage membrane for targeted and synergistic treatment of cholestasis

Cholestasis is defined as an impairment of bile acid flow leading to intrahepatic retention of toxic bile acids (BAs), which induce apoptosis or necrosis of hepatocytes and liver inflammation. Ursodeoxycholic acid (UDCA), a FDA-approved drug to treat cholestasis, has limited therapeutic effects due...

Full description

Bibliographic Details
Main Authors: Qiaoxian Huang, Zong-Ying Hu, Shuwen Guo, Dong-Sheng Guo, Ruibing Wang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2022-12-01
Series:Supramolecular Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667240522000137